Tag: AF ablation

Ablation as first-line treatment cuts AF progression compared to antiarrhythmic drugs

Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.  These were the...
ablation

Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment 

Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...

Contact force-guided ablation for typical atrial flutter does not reduce recurrent...

Contact-force (CF)-guided ablation to treat typical atrial flutter does not reduce recurrent atrial arrhythmia at 12 months follow-up, in comparison to ablation blinded for...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

CardioFocus submits HeartLight X3 PMA application to FDA

CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

Heartlight X3 gains European CE Mark

  CardioFocus has announced the European CE Mark approval for its HeartLight X3 endoscopic ablation system, used in the treatment of atrial fibrillation. The HeartLight X3 system...
Cardiac Rhythm news for specialists

Biomarkers may predict AF after catheter ablation

Researchers have identified a combination of serum biomarkers that is independently associated with higher prevalence of atrial fibrillation, and with increased incidence and recurrence...
Cardiac Rhythm news for specialists

Results of CASTLE-AF trial published: catheter ablation better than conventional drug...

The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...

Repeat ablation with contact force sensing “does not necessarily guarantee a...

Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...

CardioFocus receives approval for HeartLight Endoscopic Ablation System in Japan

CardioFocus has announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation...

Advancements in Persistent AF Ablation: New Clinical Evidence and Techniques

This webinar has been sponsored by Medtronic.  Watch the recent webinar on persistent Atrial Fibrillation (AF) ablation with Prof. Schilling (St. Barts, London), Prof. de...

First US commercial atrial fibrillation procedure with HeartLight system performed at...

CardioFocus has announced the first commercial US procedure using its HeartLight Endoscopic Ablation system for the treatment of patients with paroxysmal atrial fibrillation (AF)...